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Abstract
OBJECTIVES: To investigate the effects of body mass index (BMI) on early outcomes after revascularization using either on-pump or off-
pump surgery.
METHODS: Data for 3714 of 4314 patients who underwent surgical revascularization at our institution between 1999 and 2008 were ana-
lysed. Patients were divided into two groups [off-pump coronary artery bypass (OPCAB); n = 1958 and on-pump coronary artery bypass
(ONCAB); n = 1756] and further assigned into ﬁve classes according to their BMI (underweight <20 kg/m2, normal 20–24.99 kg/m2, over-
weight 25–29.99 kg/m2, obese 30–34.99 kg/m2 and morbidly obese ≥35 kg/m2). Thirty-day mortality, occurrence of major adverse cardiac
events (MACEs), occurrence of major non-cardiac adverse events (MNCAEs) and length of in-hospital stay were analysed in relation to BMI
only (whole cohort analysis), to BMI and chosen surgical method (ONCAB versus OPCAB) as well as confounding factors.
RESULTS: In the whole cohort analysis (n = 3714), no signiﬁcant differences between BMI classes could be identiﬁed with regard to 30-day
mortality (P = 0.78), MACEs (P = 0.72), MNCAEs (P = 0.45) or length of in-hospital stay (P = 0.94). With increasing BMI values, 30-day mortal-
ity tended to steadily increase (1.8% in BMI class ‘underweight’ vs 2.6% in BMI class ‘morbidly obese’; P = 0.78), whereas MNCAEs tended
to decrease with an increasing BMI (17.5% in BMI class ‘underweight’ vs 12.2% in BMI class ‘morbidly obese’; P = 0.45). Compared with
ONCAB, in patients with higher BMI values, OPCAB appeared to reduce slightly the frequency of 30-day mortality, MACEs and MNCAEs,
while slightly increasing the length of in-hospital stay. Adjustment for other risk factors by covariate analysis in multiple regression models
did not change the inferences drawn.
CONCLUSIONS: Our study did not detect signiﬁcant differences between BMI classes with regard to mortality and morbidity. However, a
slight trend towards a steadily increasing short-term mortality was detectable for patients with higher BMI values. When comparing
ONCAB versus OPCAB, patients with higher BMI values appeared to have a weak tendency towards a reduced short-term morbidity and
mortality in favour of OPCAB.
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INTRODUCTION
The prevalence of obesity in the USA and Europe has continuously
increased during the last decades and reached epidemic propor-
tions [1, 2].
Obesity is demonstrated as an independent risk factor and is
associated with other knownmajor risk factors/comorbidities, such
as Type 2 diabetes, hypertension and dyslipidaemia for cardiovas-
cular disease (CVD), speciﬁcally for coronary artery disease [3].
The body mass index (BMI; weight in kilograms/height2 in metres)
as a surrogate measure is commonly used in obesity classiﬁcation.
A BMI ≥30.0 kg/m2 deﬁnes obesity, whereas overweight is deﬁned
by a BMI value of 25.0–29.9 kg/m2 [4, 5].
The impact of BMI on early and late outcomes in cardiac
surgery was subject to several studies with contradictory results,
causing controversy over the usefulness of BMI as a predictive risk
factor. Whereas most of the studies focused on the impact of BMI in
patients undergoing on-pump coronary artery bypass (ONCAB) graft-
ing surgery alone or concomitant valve procedures, little is known in
the setting of off-pump coronary artery bypass (OPCAB) [6–8].
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
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The aim of the present retrospective study was to investigate
the effects of BMI on the early outcomes after on-pump versus
off-pump surgery.
MATERIALS ANDMETHODS
Data
In total, 4314 patients underwent isolated surgical revasculariza-
tion at our institution between 1999 and 2008 [9]. Data on weight
and height as required for the calculation of BMI were available
for 3714 patients. Patients were divided into two groups (OPCAB
and ONCAB) and further assigned into ﬁve classes according to
their BMI: ‘underweight’ (BMI <20 kg/m2) (n = 57), ‘normal’ (BMI
20–24.99 kg/m2) (n = 991), ‘overweight’ (BMI 25–29.99 kg/m2) (n =
1802), ‘obese’ (BMI 30–34.99 kg/m2) (n = 708) and ‘morbidly
obese’ (BMI ≥35 kg/m2) (n = 156). Among these, 1756 patients
underwent ONCAB (47.3%) and 1958 patients OPCAB (52.7%).
Deﬁnition of BMI classes used in this analysis, number of
patients per class and percentage of patients within each class
treated with ONCAB and OPCAB are summarized in Table 1.
Data collection was performed prospectively and approval by
the local institutional review board including waiver of informed
consent was obtained. Preoperative risk stratiﬁcation was per-
formed using the European System for Cardiac Operative Risk
Evaluation (EuroSCORE) risk model. Preoperative variables, demo-
graphics and assignment into BMI classes are summarized in
Tables 2 and 3.
Surgical technique
ONCAB was performed in the internationally established state of
the art techniques and cross-clamping of the aorta extensively
described elsewhere. OPCAB was carried out as previously
described [10]. In brief, after conventional median sternotomy,
harvesting of the skeletonized left and right internal mammary
artery and/or radial artery and/or reverse saphenous vein graft
(whenever possible endoscopically) was performed as needed. A
target activated clotting time >300 s was aimed for by administer-
ing heparin and repeating if necessary. After opening the pericar-
dium in a T fashion, pericardial stay sutures were placed for
cardiac exposure. Temporary epicardial pacing wires were placed,
and exposure and stabilization of the target vessel achieved by a
stabilizer (Octopus4 Tissue Stabilizer; Medtronic, Inc., Minneapolis,
MN, USA) and if necessary supported with a deep pericardial trac-
tion suture. Intraluminal shunts (ClearView Intracoronary Shunt;
Medtronic) and a blower mister (Guidant, Indianapolis, IN, USA)
with carbon dioxide and isotonic sodium chloride were used to
obtain a clear surgical ﬁeld routinely. Patency and ﬂow of anasto-
mosed grafts were routinely measured by ultrasound (MediStim
QuickFit probe; MediStim ASA, Oslo, Norway) in all patients.
Proximal anastomosis, if needed, was performed either by partial
aortic clamping using side-biting clamps or by an aortic no-touch
technique using the Heartstring device (Heartstring Proximal Seal
System; Guidant).
Statistical analysis
We evaluated three binary endpoints: 30-day mortality, occur-
rence of major adverse cardiac events (MACEs: death, myocardial
infarction, recurrent angina and stroke) and occurrence of major
non-cardiac adverse events (MNCAEs: respiratory failure, renal
failure and re-thoracotomy for bleeding), as well as the length of
in-hospital stay, in relation to BMI. The length of in-hospital
stay was analysed as a numeric response variable (log(x + 1)-
transformed). BMI values were also log-transformed to avoid a
few patients with extremely high BMI unduly inﬂuencing the
regression. Relations between outcome variables and log-
transformed BMI values were analysed with logistic regression
(binary endpoints) or linear regression (length of in-hospital stay)
and likelihood ratio tests, whereas smoothing lines from general-
ized additive models were represented in graphs. Relations
Table 1: Definition of BMI classes, number of patients per
class and percentage of patients within each class treated
with on-pump surgery (ONCAB) and off-pump surgery
(OPCAB)
BMI class BMI range
(kg/m2)
n On-pump
(%)
Off-pump
(%)
Underweight <20 57 43.9 56.1
Normal 20–24.99 991 46.8 53.2
Overweight 25–29.99 1802 48.4 51.6
Obese 30–34.99 708 45.6 54.4
Morbidly obese ≥35 156 46.2 53.8
BMI: body mass index.
Table 2: Preoperative variables, demographics and risk
factors/comorbidities according to the surgical technique:
percentage or mean ± SD in each of the BMI classes
Factors On-pump
(%)
Off-pump
(%)
P-value
Sex: female 17.1 20.0 0.024
Age (years) 62.7 ± 9.7 64.9 ± 10.1 <0.001
Diabetes 21.5 24.5 0.037
Smoking 56.8 54.4 0.19
Hypertension 61.4 49.3 <0.001
Hypercholesterolaemia 78.0 72.6 0.002
Family history of coronary disease 34.7 35.5 0.65
Ejection fraction <50% 28.9 24.5 0.003
Previous syncope 2.3 2.9 0.41
Renal disease 1.5 3.7 <0.001
COPD 7.4 5.4 0.013
Peripheral artery disease 13.4 14.6 0.31
Left main disease 25.3 30.0 0.002
Three-vessel disease 85.8 73.5 <0.001
Acute MI (<90 days) 22.2 16.6 <0.001
Previous MI (>90 days) 44.1 37.5 <0.001
Unstable angina 19.4 9.9 <0.001
IABP preoperative 24.2 10.5 <0.001
Urgent/emergent surgery 35.8 27.6 <0.001
EuroSCORE 4.0 ± 1.2 3.7 ± 1.1 <0.001
Differences among BMI classes were tested with Pearson’s chi-square
test, Fisher’s exact test or the Mann-Whitney test as appropriate.
EuroSCORE: European System for Cardiac Operative Risk Evaluation;
IABP: intra-aortic balloon pump; BMI: body mass index; COPD: chronic
obstructive pulmonary disease; MI: myocardial infarction.
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between outcome variables and BMI classes were analysed by cal-
culating percentages and Wilson 95% conﬁdence intervals (CIs)
for binary endpoints, or means and 95% CIs from log-transformed
data for the length of in-hospital stay. We further analysed the re-
lation between BMI and the effect of chosen surgical method on
the outcome. Odds ratios (ORs) for the effect of surgical method
on outcome variables were calculated separately for each BMI
class, and the signiﬁcance of differences was evaluated by testing
the interaction effect of BMI and surgical method in logistic or
linear regression. Multiple logistic or linear regression models
were used to analyse possible confounding or interactions
between effects of BMI and other risk factors. First, risk factors
found to be related to the BMI (Table 3) were added to the above-
mentioned models to check whether results are modiﬁed (con-
founding). Second, interaction effects between BMI and other risk
factors were tested. Third, all risk factors and the BMI were sub-
jected to an exhaustive model selection procedure based on the
Bayesian Information Criterion (BIC) to determine the ﬁve best
models for the prediction of each outcome variable. The same
was done with models predicting the effect of surgical method on
each outcome variable. In tables with descriptive statistics, con-
tinuous data are presented as mean ± standard deviation (SD) and
differences were tested using rank sum tests. Categorical data are
presented as percentages and differences were tested by
Pearson’s chi-square or Fisher’s exact test as appropriate.
All data were analysed in the R programming language Version
2.12.2 (R Development Core Team, 2009) using packages bestglm
and mgcv.
RESULTS
The mean BMI of all analysed patients was 27.42 ± 3.98 kg/m2.
The mean BMI in the OPCAB group was 27.47 ± 4.03 kg/m2
Table 3: Preoperative variables, demographics and risk factors/comorbidities according to BMI class: percentage or mean ± SD in
each of the BMI classes
Factor Underweight Normal Overweight Obese Morbidly obese P-value
Sex: female 38.6 20.3 15.8 20.1 26.9 <0.001
Age (years) 63.5 ± 12.4 64.3 ± 10.4 64.2 ± 10.0 63.0 ± 9.1 61.6 ± 9.6 <0.001
Diabetes 15.8 19.6 21.7 28.8 37.8 <0.001
Smoking 55.1 53.0 57.2 56.0 54.1 0.38
Hypertension 42.1 49.2 53.7 65.5 63.5 <0.001
Hypercholesterolaemia 61.5 75.1 75.9 78.4 77.3 0.16
Family history of coronary disease 22.8 35.2 35.4 35.0 36.5 0.41
Ejection fraction <50% 30.4 26.6 26.3 26.7 28.8 0.93
Previous syncope 2.6 3.2 2.1 3.2 0.8 0.28
Renal disease 2.6 3.4 1.9 1.9 2.5 0.22
COPD 17.5 5.3 6.7 5.6 7.7 0.013
Peripheral artery disease 23.2 14.6 14.2 12.9 10.3 0.15
Left main disease 21.1 26.5 28.6 28.5 25.6 0.52
Three-vessel disease 75.4 79.8 79.9 79.0 71.8 0.17
Acute MI (<90 days) 8.8 20.9 19.5 17.5 17.3 0.11
Previous MI (>90 days) 29.8 40.4 41.0 41.1 39.7 0.56
Unstable angina 7.7 16.9 15.8 16.3 14.3 0.61
IABP preoperative 19.3 16.5 17.7 15.3 18.6 0.59
Urgent/emergent surgery 40.4 31.1 31.4 32.9 26.3 0.31
EuroSCORE 3.9 ± 1.1 3.9 ± 1.1 3.8 ± 1.1 3.8 ± 1.1 3.9 ± 1.1 0.59
Differences among BMI classes were tested with Pearson’s chi-square test, Fisher’s exact test or the Kruskal–Wallis test as appropriate. BMI: body mass index;
COPD: chronic obstructive pulmonary disease; MI: myocardial infarction; IABP: intra-aortic balloon pump.
Table 4: Surgery outcomes in relation to BMI class: percentage of mortality, MACEs and MNCAEs in each BMI class and mean
duration of stay in hospital, with 95% confidence intervals
BMI class Mortality (%) MACEs (%) MNCAEs (%) In-hospital stay (days)
Underweight 1.8 (0.3–9.3) 10.5 (4.9–21.1) 17.5 (9.8–29.4) 7.6 (6.7–8.6)
Normal 1.5 (0.9–2.5) 10.5 (8.7–12.6) 12.6 (10.7–14.8) 7.9 (7.7–8.1)
Overweight 2.2 (1.6–2.9) 12.2 (10.7–13.7) 14.4 (12.9–16.1) 7.9 (7.7–8.1)
Obese 2.0 (1.2–3.3) 12.1 (9.9–14.8) 12.4 (10.2–15.1) 8.0 (7.7–8.3)
Morbidly obese 2.6 (1.0–6.4) 10.9 (6.9–16.8) 12.2 (7.9–18.2) 8.0 (7.5–8.7)
P-value 0.78 0.72 0.45 0.94
Differences among the five BMI classes were tested with logistic regression or one-way ANOVA as appropriate. BMI: body mass index; MACE: major adverse
cardiac events; MNCAE: major non-cardiac adverse events.
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and in the ONCAB group 27.38 ± 3.93 kg/m2 without signiﬁcant
difference (P = 0.60) (Table 1).
Patients in the OPCAB group were older, more often female, and
had more often diabetes, renal and gastrointestinal disease, and left
main disease. Patients in the ONCAB group had more often hyper-
tension, hypercholesterolaemia, low left ventricular ejection frac-
tion, three-vessel disease, acute or previous myocardial infarction,
and a critical preoperative state requiring intra-aortic balloon pump
(IABP) and/or urgent surgery (Table 2). In general, patients with
higher BMI were signiﬁcantly younger and had signiﬁcantly more
diabetes and hypertension (Table 3). Female patients were over-
represented in the extreme BMI classes. No further signiﬁcant rela-
tion was detected between BMI values and other risk factors/co-
morbidities or the EuroSCORE (Table 3).
Body mass index and outcome in the whole cohort
(all comers)
For all comers, no signiﬁcant differences between BMI classes
could be observed with regard to 30-day mortality (P = 0.78),
MACEs (P = 0.72), MNCAEs (P = 0.45) or length of in-hospital stay
(P = 0.94) (Table 4), and regression models only showed some
tendencies but no signiﬁcant relation of BMI values to the fre-
quency of 30-day mortality (P = 0.24), MACEs (P = 0.83), MNCAEs
(P = 0.44) and length of hospital stay (P = 0.55) (Fig. 1).
Body mass index and effect of surgical method on
outcome (ONCAB versus OPCAB)
As regards surgical methods, the comparison of outcomes after
OPCAB versus ONCAB surgery did not depend signiﬁcantly on
BMI (Table 5 and Fig. 2). OPCAB reduced the frequency of 30-day
mortality (overall OR = 0.52, 95% CI = 0.32–0.84), MACEs (OR = 0.36,
95% CI = 0.29–0.44) and MNCAEs (OR = 0.43, 95% CI = 0.35–0.52),
while increasing the length of in-hospital stay, and these effects
were similar across BMI classes. In particular, obese patients (BMI
>30) beneﬁtted equally or even slightly more from OPCAB than did
patients with lower BMI (Table 5 and Fig. 2).
Confounding by other risk factors/interaction
between effects of body mass index and other
risk factors
Adjustment for other risk factors by covariate analysis in multiple
regression models hardly modiﬁed the effects of BMI classes on
the outcomes or the interactive effects of BMI classes and surgical
method on outcome, indicating that results were not biased by
confounding effects of other risk factors (results not shown). There
was also no signiﬁcant interaction between the effects of BMI and
other risk factors (results not shown).
The ﬁve best predictive models for each of the outcomes
(found by comparing all possible models) never included the
BMI as an explanatory variable, conﬁrming the absence of signiﬁ-
cant relationships between BMI and surgical outcomes described
above. Rather, the ﬁve best models for each of the outcomes
included the following risk factors; the number of models (out of
ﬁve) including each factor is given in parentheses.
(i) Mortality: urgent/emergent surgery (5), sex (1), hypertension
(1), family history of coronary disease (1), peripheral artery
disease (1)—MACE: peripheral artery disease (5), ejection
fraction <50% (2), urgent/emergent surgery (2), instable
angina (1).
Figure 1: Relation between BMI values and surgery outcomes, that is, odds of binary endpoints (A–C) and mean duration of stay in hospital (D). Smaller values indicate
better outcomes. Smoothing lines and 95% conﬁdence bands were ﬁtted with generalized additive models. BMI: body mass index.
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(ii) MNCAEs: renal disease (5), three-vessel disease (1), urgent/
emergent surgery (1), peripheral artery disease (1), IABP pre-
operatively (1).
(iii) Duration of stay in the hospital: urgent/emergent surgery (5),
age (1), three-vessel disease (1), unstable angina (1), previous
myocardial infarction (1).
DISCUSSION
Apart from the general ongoing debate about the safety and efﬁ-
cacy of off-pump surgery [11–13], little is known about the impact
of BMI in the OPCAB setting. The results in this study
demonstrated no major impact of BMI on early outcomes in cor-
onary artery bypass grafting (CABG) regardless of the surgical
method. Interestingly, short-term mortality, MACEs and MNCAEs
appeared to be slightly reduced in OPCAB patients. Moreover, a
tendency for reduced 30-day mortality and MNCAEs in favour of
OPCAB patients could be observed with increasing BMI.
In a recent study on 6801 patients, Keeling et al. [8] reported
a decrease of in-hospital mortality for patients with a BMI value
of <25 kg/m2 after OPCAB surgery and reduced morbidity and
in-hospital mortality for OPCAB patients with higher BMI values,
which is in line with our results. The authors suggested a preferen-
tial beneﬁt for patients with a low BMI by the avoidance of
cardiopulmonary bypass and decreased levels of postoperative
Table 5: Effect of surgery method on outcomes in relation to BMI classes: odds ratios for the effect of off-pump versus on-pump
surgery on binary endpoints, and ratios of the mean duration of stay in hospital (off-pump/on-pump) with 95% confidence intervals
for each BMI class
BMI class Mortality (%) MACEs (%) MNCAEs (%) In-hospital stay (days)
Overalla 0.52 (0.32–0.84) 0.36 (0.29–0.44) 0.43 (0.35–0.52) 1.12 (1.09–1.16)
Underweight No death 0.76 (0.14–4.13) 0.27 (0.06–1.16) 1.02 (0.79–1.32)
Normal 0.58 (0.21–1.65) 0.45 (0.29–0.68) 0.48 (0.33–0.71) 1.13 (1.07–1.20)
Overweight 0.52 (0.27–1.00) 0.29 (0.21–0.40) 0.48 (0.36–0.63) 1.12 (1.07–1.17)
Obese 0.46 (0.15–1.38) 0.43 (0.27–0.68) 0.30 (0.19–0.50) 1.14 (1.06–1.22)
Morbidly obese 0.28 (0.03–2.72) 0.23 (0.07–0.73) 0.26 (0.09–0.77) 1.07 (0.92–1.24)
P-valueb 0.69 0.34 0.38 0.87
Differences among the five BMI classes were tested with logistic regression or one-way ANOVA as appropriate. MACE: major adverse cardiac events; MNCAE:
major non-cardiac adverse events.
aUnadjusted overall comparison between groups.
bAnalysis between BMI classes.
Figure 2: Relation between BMI values and the effect of surgery method (off-pump versus on-pump) on outcomes. Odds ratios (A-C) or means ratios (D) smaller than
1 indicate better outcomes with off-pump surgery. Smoothing lines and 95% conﬁdence bands were ﬁtted with generalized additive models. BMI: body mass index.
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circulating pro-inﬂammatory cytokines supporting previously
reported favourable data on early outcomes of the OPCAB tech-
nique in various groups of high-risk patients [10, 14, 15].
In two other studies, Bhamidipati et al. [6] and Prapas et al. [7]
investigated the impact of obesity and the inﬂuence of BMI on
morbidity and mortality rates in adult patients undergoing iso-
lated off-pump coronary artery bypass surgery. Their analysis of a
limited sample size of 742 and 1359 patients, respectively, showed
no signiﬁcant inﬂuence of BMI on early mortality and morbidity
after isolated OPCAB surgery.
By contrast, Potapov [16] reported in a large series of 22 666
consecutive patients that low BMI predicts increased morbidity
and mortality after cardiac surgery. Engelman et al. [17] demon-
strated earlier low BMI to be an independent predictor of worse
outcomes, whereas obesity itself did not predict an increase of
morbidity and mortality. However, these study populations com-
prised mixed cardiac procedures. Similar ﬁndings were reported
in a recent study on CABG-only patients [18]. Another study by
van Straten et al. [19] identiﬁed underweight as a predictor for
early mortality, whereas morbid obesity was a predictor for mor-
tality. Wagner et al. [20] demonstrated in a prospective study in
80 792 patients that both very low BMI and very high BMI pre-
dicted outcomes in surgical revascularization in a non-linear but
U-shaped manner.
The issue of obesity and its effect on early and late mortality in
CVD and speciﬁcally after surgical revascularization remains con-
troversial. The so-called ‘obesity paradox’ describes a protective
effect of obesity in patients with CVD in terms of better short- and
long-term prognosis compared with their leaner counterparts,
which is paradoxical given that obesity itself is regarded as an in-
dependent risk factor in this entity of patients [21–23].
However, regardless of chosen surgical method, our results
indicated a weak but statistically non-signiﬁcant tendency for
increased 30-day mortality with increasing BMI values, whereas
MNCAEs tended to decrease with an increasing BMI. In an analysis
of 559 004 patients from the Society of Thoracic Surgeons data-
base, Prabhakar et al. [24] showed extreme obesity to be a sig-
niﬁcant predictor for adverse outcomes after CABG. Recently,
Benedetto et al. [25] demonstrated in a propensity score-matched
analysis that obesity did not increase operative mortality but was
associated with reduced late survival in patients undergoing
primary isolated CABG, thus raising concerns about the ‘obesity
paradox’.
The present study has its limitations owing to its retrospective
and non-randomized design. In addition, although a total of 4314
patients underwent surgical revascularization, only 3714 patients
could be included in this study because BMI values were missing
for the remaining 600 patients (n = 14%). Furthermore, our study
cohort only contained limited numbers of patients in the
extremes of BMI, i.e. patients with BMI <20.0 kg/m2 and morbidly
obese patients with BMI ≥35.0 kg/m2, even though these groups
seem to be most controversial in the literature.
Conclusions
In summary, our study did not detect signiﬁcant differences
between BMI classes with regard to mortality and morbidity.
However, a light trend towards a steadily increase in short-term
mortality was detectable for patients with higher BMI values.
When comparing ONCAB versus OPCAB, patients with higher BMI
values appeared to have a weak tendency towards a reduced
short-term morbidity and mortality in favour of OPCAB.
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